Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth S Henson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cellular Signalling|July 4, 2006
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapyElizabeth S Henson, Spencer B Gibson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expressionElizabeth S Henson, Xiaojie Hu, Spencer B Gibson
Biochemical and Biophysical Research Communications|May 11, 2005
MEKK1-induced apoptosis is mediated by Smac/Diablo release from the mitochondriaFrancisco J Mendoza, Elizabeth S Henson, Spencer B Gibson
Plos One|June 28, 2014
Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cellsJennifer L Schacter, Elizabeth S Henson, Spencer B Gibson
Oxidative Medicine and Cellular Longevity|August 1, 2017
Lysosomes as Oxidative Targets for Cancer TherapyRebecca F Dielschneider, Elizabeth S Henson, Spencer B Gibson
Leukemia & Lymphoma|January 19, 2008
The role of TRAIL death receptors in the treatment of hematological malignanciesElizabeth S Henson, James B Johnston, Spencer B Gibson
Biologics : Targets & Therapy|August 27, 2009
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancerElizabeth S Henson, James B Johnston, Marek Los, et al.
The Journal of Biological Chemistry|January 5, 2002
MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c releaseErika M Gibson, Elizabeth S Henson, Jacylyn Villanueva, et al.
Cancers|November 26, 2022
Prostate Cancer Cells Are Sensitive to Lysosomotropic Agent Siramesine through Generation Reactive Oxygen Species and in Combination with Tyrosine Kinase InhibitorsEmily A Garcia, Ilsa Bhatti, Elizabeth S Henson, et al.
Cancer Research|January 26, 2002
Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c releaseErika M Gibson, Elizabeth S Henson, Neil Haney, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cellular Signalling|July 4, 2006
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapyElizabeth S Henson, Spencer B Gibson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expressionElizabeth S Henson, Xiaojie Hu, Spencer B Gibson
Biochemical and Biophysical Research Communications|May 11, 2005
MEKK1-induced apoptosis is mediated by Smac/Diablo release from the mitochondriaFrancisco J Mendoza, Elizabeth S Henson, Spencer B Gibson
Plos One|June 28, 2014
Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cellsJennifer L Schacter, Elizabeth S Henson, Spencer B Gibson
Oxidative Medicine and Cellular Longevity|August 1, 2017
Lysosomes as Oxidative Targets for Cancer TherapyRebecca F Dielschneider, Elizabeth S Henson, Spencer B Gibson
Leukemia & Lymphoma|January 19, 2008
The role of TRAIL death receptors in the treatment of hematological malignanciesElizabeth S Henson, James B Johnston, Spencer B Gibson
Biologics : Targets & Therapy|August 27, 2009
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancerElizabeth S Henson, James B Johnston, Marek Los, et al.
The Journal of Biological Chemistry|January 5, 2002
MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c releaseErika M Gibson, Elizabeth S Henson, Jacylyn Villanueva, et al.
Cancers|November 26, 2022
Prostate Cancer Cells Are Sensitive to Lysosomotropic Agent Siramesine through Generation Reactive Oxygen Species and in Combination with Tyrosine Kinase InhibitorsEmily A Garcia, Ilsa Bhatti, Elizabeth S Henson, et al.
Cancer Research|January 26, 2002
Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c releaseErika M Gibson, Elizabeth S Henson, Neil Haney, et al.
Pageof 3